553 related articles for article (PubMed ID: 36109667)
21. The utility of the ACR/EULAR 2017 provisional classification criteria for granulomatosis with polyangiitis in Korean patients with antineutrophil cytoplasmic antibody-associated vasculitis.
Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
Clin Exp Rheumatol; 2018; 36 Suppl 111(2):85-87. PubMed ID: 29185957
[TBL] [Abstract][Full Text] [Related]
22. [Recommendations on the diagnosis and treatment of anti-neutrophil cytoplasmic antibody associated vasculitis in China].
Tian XP; Zhao LK; Jiang ZY; Wang Y; Huang CB; Zhao Y
Zhonghua Nei Ke Za Zhi; 2022 Oct; 61(10):1128-1135. PubMed ID: 36207967
[TBL] [Abstract][Full Text] [Related]
23. Key advances in the clinical approach to ANCA-associated vasculitis.
Kallenberg CG
Nat Rev Rheumatol; 2014 Aug; 10(8):484-93. PubMed ID: 24980139
[TBL] [Abstract][Full Text] [Related]
24. Protective Role of HLA-DRB1*13:02 against Microscopic Polyangiitis and MPO-ANCA-Positive Vasculitides in a Japanese Population: A Case-Control Study.
Kawasaki A; Hasebe N; Hidaka M; Hirano F; Sada KE; Kobayashi S; Yamada H; Furukawa H; Yamagata K; Sumida T; Miyasaka N; Tohma S; Ozaki S; Matsuo S; Hashimoto H; Makino H; Arimura Y; Harigai M; Tsuchiya N
PLoS One; 2016; 11(5):e0154393. PubMed ID: 27166610
[TBL] [Abstract][Full Text] [Related]
25. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets.
Miloslavsky EM; Lu N; Unizony S; Choi HK; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Tchao NK; Fervenza F; Monach PA; Specks U; Stone JH
Arthritis Rheumatol; 2016 Dec; 68(12):2945-2952. PubMed ID: 27428559
[TBL] [Abstract][Full Text] [Related]
26. Clinical impact of subgrouping ANCA-associated vasculitis according to antibody specificity beyond the clinicopathological classification.
Deshayes S; Martin Silva N; Khoy K; Yameogo S; Mariotte D; Lobbedez T; Aouba A
Rheumatology (Oxford); 2019 Oct; 58(10):1731-1739. PubMed ID: 30805643
[TBL] [Abstract][Full Text] [Related]
27. Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?
Wallace ZS; Stone JH
Front Immunol; 2019; 10():2855. PubMed ID: 31867013
[TBL] [Abstract][Full Text] [Related]
28. Significance of clinical-immunological patterns and diagnostic yield of biopsies in microscopic polyangiitis and granulomatosis with polyangiitis.
Fernandes-Serodio J; Prieto-González S; Espígol-Frigolé G; Ríos-Garcés R; Gómez-Caverzaschi V; Araújo O; Espinosa G; Jordà-Sánchez R; Alba MA; Quintana L; Blasco M; Guillen E; Viñas O; Ruiz-Ortiz E; Pelegrín L; Sainz de la Maza M; Sánchez-Dalmau B; García-Herrera A; Solé M; Castillo P; Aldecoa I; Cano MD; Sellarés J; Hernández-González F; Agustí C; Lucena CM; López-Rueda A; Sánchez M; Benegas M; Capurro S; Sanmartí R; Grau JM; Vilaseca I; Alobid I; Cid MC; Hernández-Rodríguez J
J Intern Med; 2024 May; 295(5):651-667. PubMed ID: 38462959
[TBL] [Abstract][Full Text] [Related]
29. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis Referral Center.
Schirmer JH; Wright MN; Herrmann K; Laudien M; Nölle B; Reinhold-Keller E; Bremer JP; Moosig F; Holle JU
Arthritis Rheumatol; 2016 Dec; 68(12):2953-2963. PubMed ID: 27333332
[TBL] [Abstract][Full Text] [Related]
30. ANCA-associated vasculitis: diagnostic and therapeutic strategy.
Ozaki S
Allergol Int; 2007 Jun; 56(2):87-96. PubMed ID: 17460438
[TBL] [Abstract][Full Text] [Related]
31. Cutaneous manifestations of antineutrophil cytoplasmic antibody-associated vasculitis (AAV): a concise review with emphasis on clinical and histopathologic correlation.
Gibson LE
Int J Dermatol; 2022 Dec; 61(12):1442-1451. PubMed ID: 35599359
[TBL] [Abstract][Full Text] [Related]
32. ANCA-associated vasculitis: report from Korea.
Kim HW; Song YW
Clin Exp Nephrol; 2013 Oct; 17(5):708-711. PubMed ID: 23292177
[TBL] [Abstract][Full Text] [Related]
33. ANCA-associated vasculitis.
Kitching AR; Anders HJ; Basu N; Brouwer E; Gordon J; Jayne DR; Kullman J; Lyons PA; Merkel PA; Savage COS; Specks U; Kain R
Nat Rev Dis Primers; 2020 Aug; 6(1):71. PubMed ID: 32855422
[TBL] [Abstract][Full Text] [Related]
34. Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study.
Kim SM; Choi SY; Kim SY; Kim J
Rheumatol Int; 2019 Nov; 39(11):1919-1926. PubMed ID: 31552433
[TBL] [Abstract][Full Text] [Related]
35. Clinical impact of proteinase 3-antineutrophil cytoplasmic antibody positivity in eosinophilic granulomatosis with polyangiitis.
Ahn SS; Song JJ; Park YB; Lee SW
Korean J Intern Med; 2022 Nov; 37(6):1241-1249. PubMed ID: 34883552
[TBL] [Abstract][Full Text] [Related]
36. Clinical characteristics, the diagnostic criteria and management recommendation of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV) proposed by Japan Otological Society.
Harabuchi Y; Kishibe K; Tateyama K; Morita Y; Yoshida N; Okada M; Kunimoto Y; Watanabe T; Inagaki A; Yoshida T; Imaizumi M; Nakamura T; Matsunobu T; Kobayashi S; Iino Y; Murakami S; Takahashi H; Tono T
Auris Nasus Larynx; 2021 Feb; 48(1):2-14. PubMed ID: 32768313
[TBL] [Abstract][Full Text] [Related]
37. Spectrum of ANCA-specificities in eosinophilic granulomatosis with polyangiitis. A retrospective multicentre study.
Arnold S; Mahrhold J; Kerstein-Staehle A; Riemekasten G; Csernok E; Hellmich B; Venhoff N; Thiel J; Affeldt K; Jahnke A; Lamprecht P
Clin Exp Rheumatol; 2023 Apr; 41(4):936-942. PubMed ID: 37073637
[TBL] [Abstract][Full Text] [Related]
38. New advances in the pathogenesis of ANCA-associated vasculitides.
Chen M; Kallenberg CG
Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S108-14. PubMed ID: 19646356
[TBL] [Abstract][Full Text] [Related]
39. Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L
Ann Rheum Dis; 2013 Aug; 72(8):1273-9. PubMed ID: 23606701
[TBL] [Abstract][Full Text] [Related]
40. ANCA Status or Clinical Phenotype - What Counts More?
Windpessl M; Bettac EL; Gauckler P; Shin JI; Geetha D; Kronbichler A
Curr Rheumatol Rep; 2021 Apr; 23(6):37. PubMed ID: 33909191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
